| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.0M | +230.6% |
| Cost of Revenue | $1.3M | +322.9% |
| Gross Profit | $761K | +141.7% |
| R&D Expense | $58K | -22.5% |
| SG&A Expense | $8.2M | +86.3% |
| Operating Income | -$7.7M | -78.1% |
| Pre-tax Income | -$7.4M | -69.4% |
| Income Tax | $221K | +273.4% |
| Net Income | -$7.7M |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.8M | +17.2% |
| Short-term Investments | $8.0M | — |
| Accounts Receivable | $1.4M | — |
| Inventory | $3.9M | +988.6% |
| Current Assets | $23.0M | +311.0% |
| Total Assets | $75.3M | +1120.9% |
| Current Liabilities | $1.6M | +39.7% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.9M | -336.9% |
| Capital Expenditures | $28K | +133.0% |
| Investing Cash Flow | -$4.7M | -269.6% |
| Financing Cash Flow | $20.6M | — |
| Free Cash Flow | -$13.0M | -336.1% |
| -74.5% |
| Total Liabilities |
| $1.6M |
| +2.1% |
| Stockholders' Equity | $73.7M | +1491.0% |